Rachel E. Factor

6.1k total citations · 1 hit paper
62 papers, 2.3k citations indexed

About

Rachel E. Factor is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Rachel E. Factor has authored 62 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 18 papers in Cancer Research and 13 papers in Molecular Biology. Recurrent topics in Rachel E. Factor's work include Breast Cancer Treatment Studies (15 papers), Breast Lesions and Carcinomas (9 papers) and Cancer Genomics and Diagnostics (6 papers). Rachel E. Factor is often cited by papers focused on Breast Cancer Treatment Studies (15 papers), Breast Lesions and Carcinomas (9 papers) and Cancer Genomics and Diagnostics (6 papers). Rachel E. Factor collaborates with scholars based in United States, Malawi and United Kingdom. Rachel E. Factor's co-authors include Katharine S. Ullman, Robert L. Schmidt, Alana L. Welm, Philip S. Bernard, Inge J. Stijleman, Leigh Neumayer, Mark Ebbert, Cindy Matsen, Saundra S. Buys and Yoko S. DeRose and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Nature reviews. Cancer.

In The Last Decade

Rachel E. Factor

57 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes

2011 699 citations Philip S. Bernard, Mark Ebbert et al. profile →

Peers

Countries citing papers authored by Rachel E. Factor

Since Specialization

Citations

This map shows the geographic impact of Rachel E. Factor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel E. Factor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel E. Factor more than expected).

Fields of papers citing papers by Rachel E. Factor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel E. Factor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel E. Factor. The network helps show where Rachel E. Factor may publish in the future.

Co-authorship network of co-authors of Rachel E. Factor

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel E. Factor. A scholar is included among the top collaborators of Rachel E. Factor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel E. Factor. Rachel E. Factor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	X-ray diffraction imaging of glioblastoma and ductal carcinoma in-situ 2024 ·Joel A. Greenberg, (unknown), (unknown), Xiang Li, (unknown), (unknown), Rachel E. Factor, Shannon J. McCall, Anuj Kapadia	0
2	Myeloid Sarcoma of the Breast: A Diagnostic Dilemma With Pathologic Correlation 2023 ·Journal of Breast Imaging ·(unknown), Rachel E. Factor, (unknown), (unknown), Sujata V. Ghate	0
3	Comparison of Diagnostic Sensitivity and Procedure-Related Pain of Concurrent Ultrasound-guided Fine-needle Aspiration and Core-needle Biopsy of Axillary Lymph Nodes in Patients with Suspected or Known Breast Cancer 2023 ·Journal of Breast Imaging ·Nicole Winkler, (unknown), Phoebe E. Freer, (unknown), (unknown), Kenneth M. Boucher, (unknown), Rachel E. Factor	4
4	A Multigene Assay Determines Risk of Recurrence in Patients with Triple-Negative Breast Cancer 2019 ·Cancer Research ·Rachel L. Stewart, (unknown), Rachel E. Factor, N. Lynn Henry, Kenneth M. Boucher, Philip S. Bernard, Katherine E. Varley	35
5	Reparameterization of PAM50 Expression Identifies Novel Breast Tumor Dimensions and Leads to Discovery of a Genome-Wide Significant Breast Cancer Locus at 12q15 2018 ·Cancer Epidemiology Biomarkers & Prevention ·(unknown), Stacey Knight, Carol Sweeney, Rachel E. Factor, Mohamed E. Salama, Inge J. Stijleman, Venkatesh Rajamanickam, Bryan E. Welm, Sasi Arunachalam, Brandt Jones, (unknown), Kerry Rowe, Melissa H. Cessna, Alun Thomas, Lawrence H. Kushi, Bette J. Caan, Philip S. Bernard, Nicola J. Camp	7
6	BRCA1 through Its E3 Ligase Activity Regulates the Transcription Factor Oct1 and Carbohydrate Metabolism 2018 ·Molecular Cancer Research ·Karina Vázquez-Arreguín, Jessica Maddox, Jinsuk Kang, Dongju Park, (unknown), Rachel E. Factor, Thomas Ludwig, Dean Tantin	17
7	HER2 immunohistochemical and fluorescence in situ hybridization discordances in invasive breast carcinoma with micropapillary features 2017 ·Modern Pathology ·Rachel L. Stewart, (unknown), Evin Gulbahce, Rachel E. Factor, Katherine B. Geiersbach, Erinn Downs‐Kelly	21
8	Intrinsic Subtypes from PAM50 Gene Expression Assay in a Population-Based Breast Cancer Cohort: Differences by Age, Race, and Tumor Characteristics 2014 ·Cancer Epidemiology Biomarkers & Prevention ·Carol Sweeney, Philip S. Bernard, Rachel E. Factor, Marilyn L. Kwan, Laurel A. Habel, Charles P. Quesenberry, (unknown), Erin Weltzien, Inge J. Stijleman, Carole Davis, Mark Ebbert, Adrienne Castillo, Lawrence H. Kushi, Bette J. Caan	94
9	Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression 2014 ·Breast Cancer Research and Treatment ·Candyce H. Kroenke, Carol Sweeney, Marilyn L. Kwan, Charles P. Quesenberry, Erin Weltzien, Laurel A. Habel, Adrienne Castillo, (unknown), Rachel E. Factor, Lawrence H. Kushi, Bette J. Caan	36
10	In vivo evaluation of a breast‐specific magnetic resonance guided focused ultrasound system in a goat udder model 2013 ·Medical Physics ·Allison Payne, Nick Todd, (unknown), Y. Wang, (unknown), (unknown), (unknown), Rachel E. Factor, Leigh Neumayer, Dennis L. Parker	21
11	Clinician compliance with laboratory regulations requiring submission of relevant clinical data: A one year retrospective analysis 2012 ·Pathology - Research and Practice ·Lester J. Layfield, Rachel E. Factor, Elke A. Jarboe	5
12	The nuclear envelope environment and its cancer connections 2012 ·Nature reviews. Cancer ·(unknown), Rachel E. Factor, Katharine S. Ullman	261
13	Protein Arginine Methyltransferase 5 Accelerates Tumor Growth by Arginine Methylation of the Tumor Suppressor Programmed Cell Death 4 2011 ·Cancer Research ·Matthew A. Powers, Marta M. Fay, Rachel E. Factor, Alana L. Welm, Katharine S. Ullman	122
14	Fine‐needle aspiration diagnosis of an intraosseous amyloidoma 2011 ·Diagnostic Cytopathology ·Rachel E. Factor, Lester J. Layfield, Allie H. Grossmann, Julia R. Crim, (unknown), R V Randall	6
15	Intraprocedural evaluation of fine‐needle aspiration smears: How good are we? 2011 ·Diagnostic Cytopathology ·Rachel E. Factor, Lester J. Layfield	4
16	Methods Specification for Diagnostic Test Accuracy Studies in Fine-Needle Aspiration Cytology 2011 ·American Journal of Clinical Pathology ·Robert L. Schmidt, Rachel E. Factor, Kajsa E. Affolter, (unknown), Brian J. Hall, Krishna K. Narra, Benjamin L. Witt, Andrew Wilson, Lester J. Layfield	9
17	Diagnostic Efficacy and Safety of Computed Tomography-Guided Transthoracic Needle Biopsy in Patients with Hematologic Malignancies 2009 ·Academic Radiology ·(unknown), Ritu R. Gill, Rachel E. Factor, Julie M. Bryar, Robert H. Rubin, Francine L. Jacobson, Francisco M. Marty	15
18	Cytogenetics and fluorescence in situ hybridization as adjuncts to cytology in the diagnosis of malignant mesothelioma 2009 ·Cancer Cytopathology ·Rachel E. Factor, Paola Dal Cin, Jonathan A. Fletcher, Edmund S. Cibas	18
19	An HIV‐Infected Man with an Upset Stomach: (Answer on pages 979–80) 2008 ·Clinical Infectious Diseases ·Mohammed Asmal, Rachel E. Factor, Rochelle P. Walensky	1
20	Potent suppression of IL-12 production from monocytes and dendritic cells during endotoxin tolerance 1998 ·European Journal of Immunology ·Christopher L. Karp, Maria Wysocka, Xiaojing Ma, Mary Marovich, Rachel E. Factor, Thomas B. Nutman, Myriam Armant, Larry M. Wahl, (unknown), Giorgio Trinchieri	122

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact